Published online before print February 14, 2002, doi: 10.1161/01.RES.0000012922.40318.05
© 2002 American Heart Association, Inc.
Molecular Medicine |
Identification of IEX-1 as a Biomechanically Controlled Nuclear Factor-
B Target Gene That Inhibits Cardiomyocyte Hypertrophy
From the Cardiovascular Division, Department of Medicine (G.W.D.K., Y.W., Y.F., S.M., K.Y., R.T.L.), Brigham and Women’s Hospital, Harvard Medical School, Cambridge, Mass; and Pfizer Global Research and Development (J.F.T., T.G.T., K.L.), Groton, Conn.
Correspondence to Richard T. Lee, MD, Cardiovascular Division, Brigham and Women’s Hospital, 65 Landsdowne St, Cambridge, MA 02139. E-mail rlee{at}rics.bwh.harvard.edu
Biomechanical strain is a stimulus for cardiomyocyte hypertrophy and heart failure, but the underlying molecular mechanisms remain incompletely understood. Using an in vivo murine model of pressure overload and an in vitro model of mechanical stimulation of primary cardiomyocytes, we identified iex-1 as a gene activated during the early response of cardiomyocytes to hypertrophic stimuli and as a gene product that inhibits hypertrophy without affecting cardiomyocyte viability. On stimulation of cardiomyocytes, iex-1 mRNA and protein expression increased and translocation of the gene product to the cardiomyocyte nucleus occurred. iex-1 has previously been proposed as a mediator of NF-
B-dependent cell survival and growth in tumor cells. Here, we demonstrate that the biomechanical induction of iex-1 in cardiomyocytes was NF-B-dependent, as overexpression of the NF-B inhibitor IB
completely inhibited strain-mediated iex-1 mRNA accumulation. The functional role of iex-1 was investigated by overexpressing wild-type iex-1 with replication-defective adenoviral gene transfer. Overexpression of iex-1 abolished cardiomyocyte hypertrophy by mechanical strain, phenylephrine, or endothelin-1 at levels that did not affect cell viability. These studies identify iex-1 as a biomechanical stress-inducible and NF-B-dependent gene in cardiac muscle cells during the acute phase of hypertrophy with negative growth regulatory effects that may counterbalance early hypertrophic responses in activated cardiomyocytes.
Key Words: hypertrophy • apoptosis • biomechanical strain • cardiomyocytes • heart failure
This article has been cited by other articles:
 |
|
 |
|
  J. M. Holaska Emerin and the Nuclear Lamina in Muscle and Cardiac Disease Circ. Res., July 3, 2008; 103(1): 16 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Bergmann and L. J. De Windt Linking Cardiac Mechanosensing at the Sarcomere M-Band, Nuclear Factor {kappa}B Signaling, and Cardiac Remodeling Hypertension, June 1, 2007; 49(6): 1225 - 1227. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lemmens, V. F.M. Segers, M. Demolder, M. Michiels, P. Van Cauwelaert, and G. W. De Keulenaer Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy Eur J Heart Fail, April 1, 2007; 9(4): 352 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Sommer, T. J. Berndt, E. Frank, J. B. Patel, M. M. Redfield, X. Dong, M. D. Griffin, J. P. Grande, J. M. A. van Deursen, G. C. Sieck, et al. Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene J Appl Physiol, February 1, 2006; 100(2): 707 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lammerding, J. Hsiao, P. C. Schulze, S. Kozlov, C. L. Stewart, and R. T. Lee Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells J. Cell Biol., August 29, 2005; 170(5): 781 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-L. Kruse, A. Arlt, A. Sieke, F. Grohmann, M. Grossmann, J. Minkenberg, U. R. Folsch, and H. Schafer Immediate Early Gene X1 (IEX-1) Is Organized in Subnuclear Structures and Partially Co-localizes with Promyelocytic Leukemia Protein in HeLa Cells J. Biol. Chem., July 1, 2005; 280(26): 24849 - 24856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Freund, R. Schmidt-Ullrich, A. Baurand, S. Dunger, W. Schneider, P. Loser, A. El-Jamali, R. Dietz, C. Scheidereit, and M. W. Bergmann Requirement of Nuclear Factor-{kappa}B in Angiotensin II- and Isoproterenol-Induced Cardiac Hypertrophy In Vivo Circulation, May 10, 2005; 111(18): 2319 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Hui, W. Zhang, W. Chen, D. Xi, B. Purow, G. C. Friedman, and H. A. Fine Agents with Selective Estrogen Receptor (ER) Modulator Activity Induce Apoptosis In vitro and In vivo in ER-Negative Glioma Cells Cancer Res., December 15, 2004; 64(24): 9115 - 9123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E Hardt and J. Sadoshima Negative regulators of cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 500 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lehoux and A. Tedgui All Strain, No Gain: Stretch Keeps Proliferation at Bay via the NF-{kappa}B Response Gene iex-1 Circ. Res., December 12, 2003; 93(12): 1139 - 1141. [Full Text] [PDF]
|
|
|
|
|
|
P. C. Schulze, G. W. de Keulenaer, K. A. Kassik, T. Takahashi, Z. Chen, D. I. Simon, and R. T. Lee Biomechanically Induced Gene iex-1 Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation Circ. Res., December 12, 2003; 93(12): 1210 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Schmitt, C. Semsarian, M. Arad, J. Gannon, F. Ahmad, C. Duffy, R. T. Lee, C. E. Seidman, and J.G. Seidman Consequences of Pressure Overload on Sarcomere Protein Mutation-Induced Hypertrophic Cardiomyopathy Circulation, September 2, 2003; 108(9): 1133 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Purcell and J. D. Molkentin Is Nuclear Factor {kappa}B an Attractive Therapeutic Target for Treating Cardiac Hypertrophy? Circulation, August 12, 2003; 108(6): 638 - 640. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Cook, M. S. Novikov, Y. Ahn, T. Matsui, and A. Rosenzweig A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response Circulation, August 12, 2003; 108(6): 664 - 667. [Abstract] [Full Text] [PDF]
|
|